Nivolumab Versus Placebo In Relapsed Malignant Mesothelioma: The Confirm Phase 3 Trial
JOURNAL OF THORACIC ONCOLOGY(2021)
关键词
Phase III trial, Relapsed Malignant Mesothelioma, Immune-checkpoint-inhibitor
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要